Hepatitis B and C Viral Infections among Dialysis Patients and Related Factors of Dialysis Centres in Saudi Arabia

Introduction: Viral Hepatitis is a global disease, affecting millions of patients around the world. Dialysis dependent patients use an artificial kidney (haemodialyser) to remove waste product from the blood in severe renal impairment patients. Hence, they are more vulnerable to viral hepatitis. Ai...

Full description

Bibliographic Details
Main Author: Badr M Aljarallah
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2022-01-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/15922/52072_CE[Ra1]_F(KM)_PF1(SC_SS)_PFA2(SC_KM)_PN(KM).pdf
_version_ 1811175315966263296
author Badr M Aljarallah
author_facet Badr M Aljarallah
author_sort Badr M Aljarallah
collection DOAJ
description Introduction: Viral Hepatitis is a global disease, affecting millions of patients around the world. Dialysis dependent patients use an artificial kidney (haemodialyser) to remove waste product from the blood in severe renal impairment patients. Hence, they are more vulnerable to viral hepatitis. Aim: To investigate the prevalence of hepatitis B and C infections among dialysis patients and related factors of dialysis centres in the Qassim province, Saudi Arabia. Materials and Methods: This cross-sectional study, reviewed the medical records of 707 patients from the data registry of 18 affiliated dialysis centres across Al Qassim region of Saudi Arabia, during August 2017 to August 2018. A detailed questionnaire regarding the general information about the dialysis centre, isolation and screen status, vaccination status, and vascular access was completed by the Dialysis Centre Manager of all the 18 affiliated centres. The details of Hepatitis B Surface Antigen (HBsAg) and Hepatitis C Virus (HCV) serology reports were extracted to establish the prevalence and epidemiological profile of these patients. Descriptive analysis was conducted where numbers and percentages were used to summarise all categorical variables. Results: The majority 14 (77.8%) of the centres were government entities and the rest were for profit centres. Out of the 18 centres, 10 (55.6%) were hospital based, 5 (27.8%) were free-standing and 3 (16.7%) were free-standing but owned by a hospital. The prevalence of HBsAg positive cases among incentre haemodialysis patients was 3.2% and the prevalence of Hepatitis C (HBC) antibody positive cases was 6.4% with 0.3% cases of the HBsAg and HBC converted to positive during the previous 12 months. Conclusion: The incidence of hepatitis B and C positivity was common in patients receiving haemodialysis. The study found low prevalence of both Hepatitis B and C positive cases in comparison to several published articles. The decrease in HBV and HBC prevalence seen in the present study may be attributable to the development and implementation of preventive strategies, increased adherence by medical staff to aseptic measures, better infection management, immunisation, and isolation of affected patients. However, further studies are needed to generalise the outcome of the present study.
first_indexed 2024-04-10T19:34:01Z
format Article
id doaj.art-081a80434e94471896765e1977a5b374
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-04-10T19:34:01Z
publishDate 2022-01-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-081a80434e94471896765e1977a5b3742023-01-30T08:55:23ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2022-01-01161OC28OC3110.7860/JCDR/2022/52072.15922Hepatitis B and C Viral Infections among Dialysis Patients and Related Factors of Dialysis Centres in Saudi ArabiaBadr M Aljarallah0Associate Professor, Department of Gastroenterology and Hepatology, Qassim College of Medicine, Qassim University, Qassim, Buraida, Saudi Arabia.Introduction: Viral Hepatitis is a global disease, affecting millions of patients around the world. Dialysis dependent patients use an artificial kidney (haemodialyser) to remove waste product from the blood in severe renal impairment patients. Hence, they are more vulnerable to viral hepatitis. Aim: To investigate the prevalence of hepatitis B and C infections among dialysis patients and related factors of dialysis centres in the Qassim province, Saudi Arabia. Materials and Methods: This cross-sectional study, reviewed the medical records of 707 patients from the data registry of 18 affiliated dialysis centres across Al Qassim region of Saudi Arabia, during August 2017 to August 2018. A detailed questionnaire regarding the general information about the dialysis centre, isolation and screen status, vaccination status, and vascular access was completed by the Dialysis Centre Manager of all the 18 affiliated centres. The details of Hepatitis B Surface Antigen (HBsAg) and Hepatitis C Virus (HCV) serology reports were extracted to establish the prevalence and epidemiological profile of these patients. Descriptive analysis was conducted where numbers and percentages were used to summarise all categorical variables. Results: The majority 14 (77.8%) of the centres were government entities and the rest were for profit centres. Out of the 18 centres, 10 (55.6%) were hospital based, 5 (27.8%) were free-standing and 3 (16.7%) were free-standing but owned by a hospital. The prevalence of HBsAg positive cases among incentre haemodialysis patients was 3.2% and the prevalence of Hepatitis C (HBC) antibody positive cases was 6.4% with 0.3% cases of the HBsAg and HBC converted to positive during the previous 12 months. Conclusion: The incidence of hepatitis B and C positivity was common in patients receiving haemodialysis. The study found low prevalence of both Hepatitis B and C positive cases in comparison to several published articles. The decrease in HBV and HBC prevalence seen in the present study may be attributable to the development and implementation of preventive strategies, increased adherence by medical staff to aseptic measures, better infection management, immunisation, and isolation of affected patients. However, further studies are needed to generalise the outcome of the present study.https://www.jcdr.net/articles/PDF/15922/52072_CE[Ra1]_F(KM)_PF1(SC_SS)_PFA2(SC_KM)_PN(KM).pdfhaemodialysisvaccination statusvascular access
spellingShingle Badr M Aljarallah
Hepatitis B and C Viral Infections among Dialysis Patients and Related Factors of Dialysis Centres in Saudi Arabia
Journal of Clinical and Diagnostic Research
haemodialysis
vaccination status
vascular access
title Hepatitis B and C Viral Infections among Dialysis Patients and Related Factors of Dialysis Centres in Saudi Arabia
title_full Hepatitis B and C Viral Infections among Dialysis Patients and Related Factors of Dialysis Centres in Saudi Arabia
title_fullStr Hepatitis B and C Viral Infections among Dialysis Patients and Related Factors of Dialysis Centres in Saudi Arabia
title_full_unstemmed Hepatitis B and C Viral Infections among Dialysis Patients and Related Factors of Dialysis Centres in Saudi Arabia
title_short Hepatitis B and C Viral Infections among Dialysis Patients and Related Factors of Dialysis Centres in Saudi Arabia
title_sort hepatitis b and c viral infections among dialysis patients and related factors of dialysis centres in saudi arabia
topic haemodialysis
vaccination status
vascular access
url https://www.jcdr.net/articles/PDF/15922/52072_CE[Ra1]_F(KM)_PF1(SC_SS)_PFA2(SC_KM)_PN(KM).pdf
work_keys_str_mv AT badrmaljarallah hepatitisbandcviralinfectionsamongdialysispatientsandrelatedfactorsofdialysiscentresinsaudiarabia